NCT07538921

Brief Summary

This study aims to clinically and radiographically evaluate the effect of Concentrated Growth Factors (CGF) on the outcomes of autotransplantation of closed apex teeth. Tooth autotransplantation is considered a viable treatment option for replacing missing teeth; however, its success may be influenced by factors such as periodontal healing and pulpal revascularization, especially in teeth with closed apices. Concentrated Growth Factors (CGF), as an advanced generation of platelet concentrates, are rich in growth factors that may enhance tissue regeneration, promote healing, and improve the success rate of transplanted teeth. In this study, patients requiring tooth autotransplantation will be treated using CGF at the recipient site. Clinical outcomes, including tooth stability, periodontal health, and presence of complications, will be assessed. Radiographic evaluation will be performed to monitor bone healing, root resorption, and periodontal ligament integrity over a defined follow-up period. The findings of this study are expected to provide evidence regarding the potential benefits of CGF in improving the success and prognosis of autotransplanted closed apex teeth.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7

participants targeted

Target at below P25 for not_applicable

Timeline
13mo left

Started Jun 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 13, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 20, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

June 1, 2026

Expected
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2027

1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2027

Last Updated

May 7, 2026

Status Verified

April 1, 2026

Enrollment Period

1 year

First QC Date

April 13, 2026

Last Update Submit

May 1, 2026

Conditions

Keywords

closed apex teeth AT

Outcome Measures

Primary Outcomes (1)

  • Changes in Radiographic Bone Density at the Recipient Site

    Radiographic assessment of bone density at the recipient site will be performed using CBCT imaging to evaluate bone healing over time.

    6 months

Study Arms (1)

CGF assisted auto transplantation

EXPERIMENTAL

Participants in this arm will undergo autotransplantation of teeth with closed apices using a standardized surgical protocol. Concentrated Growth Factors (CGF) will be prepared from the patient's own blood and applied to the recipient site prior to placement of the donor tooth. The transplanted tooth will then be stabilized using an appropriate splinting technique. Patients will be followed up clinically and radiographically to assess healing outcomes and treatment success.

Procedure: closed apex teeth auto transplantation

Interventions

In this study, autotransplantation of teeth with closed apices will be performed following standard surgical protocols. The donor tooth will be atraumatically extracted with maximum preservation of the periodontal ligament, and the recipient socket will be carefully prepared to receive the transplanted tooth. In the intervention group, Concentrated Growth Factors (CGF) will be prepared from the patient's venous blood using a standardized centrifugation protocol. The obtained CGF will be applied to the recipient socket prior to placement of the donor tooth to enhance healing and promote tissue regeneration.

CGF assisted auto transplantation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Donor Tooth : any 3rd molar tooth with fully developed roots (confirmed radiographically) and not functionally used (semi impacted, impacted but easily to be extracted, absence of the opposing etc…) .
  • Recipient Site : Recipient 1st or 2nd molar region (either upper or lower) with adequate bone volume to receive the auto transplanted tooth.
  • Oral Health: Good general oral hygiene and absence of active periodontal disease.
  • Systemic Health: patients with no contraindications for minor oral surgery.

You may not qualify if:

  • Poor Oral Hygiene: Presence of uncontrolled gingivitis or periodontitis.
  • Systemic Conditions: Patients with systemic diseases that may impair healing (e.g., uncontrolled diabetes, immunosuppression, bleeding disorders or bone metabolic diseases ).
  • Smoking: Active smokers or tobacco users.
  • Pregnancy or Lactation: Female patients who are pregnant or breastfeeding

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of oral and dental surgery cairo university

Cairo, Elmanial, Egypt

Location

Related Publications (3)

  • Keranmu D, Ainiwaer A, Nuermuhanmode N, Ling W. Application of concentrated growth factor to autotransplantation with inflammation in recipient area. BMC Oral Health. 2021 Oct 30;21(1):556. doi: 10.1186/s12903-021-01915-3.

  • Czochrowska EM, Stenvik A, Bjercke B, Zachrisson BU. Outcome of tooth transplantation: survival and success rates 17-41 years posttreatment. Am J Orthod Dentofacial Orthop. 2002 Feb;121(2):110-9; quiz 193. doi: 10.1067/mod.2002.119979.

  • Chen J, Wan Y, Lin Y, Jiang H. Considerations for Clinical Use of Concentrated Growth Factor in Maxillofacial Regenerative Medicine. J Craniofac Surg. 2021 Jun 1;32(4):1316-1321. doi: 10.1097/SCS.0000000000007182.

Study Officials

  • Nesrine Mohammed Khairy, Professor of OMFS

    Cairo University

    STUDY CHAIR
  • Abdelmoez Mohamed El-Sharkawy, Associate Professor

    Cairo University

    STUDY DIRECTOR
  • Ahmed Mohamed Sayed, master degree

    Cairo University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ahmed Mohamed Sayed, Master Degree

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: A Case series Study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

April 13, 2026

First Posted

April 20, 2026

Study Start (Estimated)

June 1, 2026

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

July 1, 2027

Last Updated

May 7, 2026

Record last verified: 2026-04

Locations